# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-22-012261
Filing Date
2022-05-05
Accepted
2022-05-05 16:31:55
Documents
92
Period of Report
2022-03-31

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 |  | form10q.htm iXBRL | 10-Q | 1079305
2 |  | ex31-1.htm | EX-31.1 | 18056
3 |  | ex31-2.htm | EX-31.2 | 18122
4 |  | ex32-1.htm | EX-32.1 | 8006
| Complete submission text file | 0001493152-22-012261.txt |  | 6845263

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
5 | XBRL SCHEMA FILE | hrow-20220331.xsd | EX-101.SCH | 59829
6 | XBRL CALCULATION FILE | hrow-20220331_cal.xml | EX-101.CAL | 83371
7 | XBRL DEFINITION FILE | hrow-20220331_def.xml | EX-101.DEF | 300422
8 | XBRL LABEL FILE | hrow-20220331_lab.xml | EX-101.LAB | 479260
9 | XBRL PRESENTATION FILE | hrow-20220331_pre.xml | EX-101.PRE | 397019
86 | EXTRACTED XBRL INSTANCE DOCUMENT | form10q_htm.xml | XML | 1024413

Mailing Address 102 WOODMONT BLVD SUITE 610 NASHVILLE TN 37215
Business Address 102 WOODMONT BLVD SUITE 610 NASHVILLE TN 37215 615.733.4731
HARROW HEALTH, INC. (Filer) CIK: 0001360214 (see all company filings)

EIN.: 450567010 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35814 | Film No.: 22896908
SIC: 2834 Pharmaceutical Preparations